Research and Development
Innovation is being stifled – Lilly chief executive
February 10, 2011 Research and Development, Sales and Marketing Economist 2011 Pharma Summit, US health reforms, healthcare costs, healthcare reform, lilly
Digital Pharma: This is how pharma is using digital
February 10, 2011 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Android, Digital Pharma blog, Facebook, Twitter, disease awareness campaigns, ipad, iphone, social media
WHO wants narcolepsy link with swine flu vaccine investigated
February 10, 2011 Research and Development, Sales and Marketing Finland Institute, GSK, GlaxoSmithKline, Pandemrix, narcolepsy, swine flu
Dr Mikael von Euler moves to Oncos Therapeutics
February 10, 2011 Research and Development Dr Mikael von Euler, Oncos Therapeutics, appointment, research and development
Shire bags senior research execs from GSK and Abbott
February 9, 2011 Research and Development Dr Lawson Macartney, Dr Mario Saltarelli, Shire, appointment, recruitment, research and development
Dr Matthias joins Noxxon Pharma
February 9, 2011 Research and Development Dr Matthias Baumann, Noxxon Pharma, appointment, research and development
Melanoma: intense competition to be the next milestone treatment
February 9, 2011 Research and Development BRAF V600 mutation, Cancer, Tasigna, cancer research, melanoma, tremelimumab
AZ-Targacept depression candidate moves into phase IIb
February 9, 2011 Research and Development AZ, AstraZeneca, TC-5214, Targacept, depression, major depressive disorder
AZ and Pfizer support personalised medicine database
February 8, 2011 Research and Development AZ, AstraZeneca, Cancer Research UK, Iressa, Pfizer, crizotinib, gefitinib, personalised medicine
Pressure mounts on Pfizer and government over UK R&D closure
February 7, 2011 Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee
Late-stage blow to AstraZeneca’s prostate cancer drug
February 7, 2011 Research and Development AstraZeneca, Cancer, prostate cancer, zibotentan
Bayer’s regorafenib gains orphan status for GIST
February 4, 2011 Research and Development, Sales and Marketing Bayer, FDA, GIST, gastrointestinal stromal tumours, orphan drug, regorafenib
ABPI backs UK science after Pfizer’s R&D exit
February 4, 2011 Research and Development Kent, Pfizer, Sandwich
Working Life: Merck Sharp & Dohme medical director Paul Robinson
February 4, 2011 Business Services, Research and Development MSD, Paul Robinson, Working Life, careers, merck sharp and dohme, recruitment
Five capabilities of centered leadership
February 3, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Caroline Webb, Joanna Barsh, Josephine Mogelof, McKinsey & Company, leadership
Latest content
Highlighting the value of lab research for healthcare innovation
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO
